Drawing for ALTABAX

USPTO serial 78618953

ALTABAX

Reviewed by CopyMark Law Group

Reg. 3330992Status 800Renewal
Filing date
Status date
Registration date
Nov 6, 2007
Examiner
GARTNER, JOHN M
Law office
TMO LAW OFFICE 119

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with ALTABAX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JOHN P. MURTAUGH

JOHN P. MURTAUGH PEARNE & GORDON LLP1801 EAST 9TH STREET, SUITE 1200CLEVELAND, OH 44114-3108UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Topical antibiotic preparations used to treat and/or prevent skin infectionsACTIVEMay 7, 2007

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 7, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Oct 19, 2017NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Oct 19, 2017RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Oct 19, 201789AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Oct 18, 2017EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Oct 11, 2017PR89POST REGISTRATION ACTION MAILED - SEC. 8 & 9—
Oct 11, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 11, 201789AFREGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED—
Sep 11, 2017E89RTEAS SECTION 8 & 9 RECEIVED—
Aug 16, 2017ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 6, 2016REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Mar 26, 2013NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 26, 2013C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 26, 2013APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 20, 2013CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 20, 2013COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 7, 2013E815TEAS SECTION 8 & 15 RECEIVED—
May 12, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 6, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 6, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 6, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 4, 2007REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Oct 4, 2007ALIEASSIGNED TO LIE—
Sep 5, 2007CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 31, 2007SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 9, 2007IUAFUSE AMENDMENT FILED—
Aug 9, 2007EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 24, 2006EX2GSOU EXTENSION 2 GRANTED—
Oct 24, 2006EXT2SOU EXTENSION 2 FILED—
Oct 24, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 2, 2006EX1GSOU EXTENSION 1 GRANTED—
Aug 2, 2006EXT1SOU EXTENSION 1 FILED—
Aug 2, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 21, 2006NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 27, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 7, 2005NPUBNOTICE OF PUBLICATION—
Nov 9, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 4, 2005ALIEASSIGNED TO LIE—
Nov 3, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 3, 2005GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 3, 2005CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 3, 2005DOCKASSIGNED TO EXAMINER—
May 11, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance